Literature DB >> 21835318

Allopurinol a new anti-ischemic role for an old drug.

Peter H Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21835318     DOI： 10.1016/j.jacc.2011.02.072

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  8 in total

Review 1.  Drug Therapy for Stable Angina Pectoris.

Authors:  Talla A Rousan; Sunil T Mathew; Udho Thadani
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

2.  Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.

Authors:  Michael M Givertz; Kevin J Anstrom; Margaret M Redfield; Anita Deswal; Haissam Haddad; Javed Butler; W H Wilson Tang; Mark E Dunlap; Martin M LeWinter; Douglas L Mann; G Michael Felker; Christopher M O'Connor; Steven R Goldsmith; Elizabeth O Ofili; Mitchell T Saltzberg; Kenneth B Margulies; Thomas P Cappola; Marvin A Konstam; Marc J Semigran; Steven E McNulty; Kerry L Lee; Monica R Shah; Adrian F Hernandez
Journal:  Circulation       Date:  2015-04-14       Impact factor: 29.690

3.  Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study.

Authors:  Michael M Givertz; Douglas L Mann; Kerry L Lee; Jenny C Ibarra; Eric J Velazquez; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  Circ Heart Fail       Date:  2013-07       Impact factor: 8.790

4.  Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.

Authors:  Hany M El-Bassossy; Malcolm L Watson
Journal:  J Transl Med       Date:  2015-03-06       Impact factor: 5.531

5.  Xanthine oxidase inhibitors in ischaemic heart disease.

Authors:  Mihnea Zdrenghea; Adela Sitar-Tăut; Gabriel Cismaru; Dumitru Zdrenghea; Dana Pop
Journal:  Cardiovasc J Afr       Date:  2016-09-09       Impact factor: 1.167

6.  Promising effects of xanthine oxidase inhibition by allopurinol on autonomic heart regulation estimated by heart rate variability (HRV) analysis in rats exposed to hypoxia and hyperoxia.

Authors:  Stanisław Zajączkowski; Wiesław Ziółkowski; Piotr Badtke; Miłosz A Zajączkowski; Damian J Flis; Adam Figarski; Maria Smolińska-Bylańska; Tomasz H Wierzba
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

7.  Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study.

Authors:  Victor C Kok; Jorng-Tzong Horng; Wan-Shan Chang; Ya-Fang Hong; Tzu-Hao Chang
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

8.  Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.

Authors:  Jon White; Reecha Sofat; Gibran Hemani; Tina Shah; Jorgen Engmann; Caroline Dale; Sonia Shah; Felix A Kruger; Claudia Giambartolomei; Daniel I Swerdlow; Tom Palmer; Stela McLachlan; Claudia Langenberg; Delilah Zabaneh; Ruth Lovering; Alana Cavadino; Barbara Jefferis; Chris Finan; Andrew Wong; Antoinette Amuzu; Ken Ong; Tom R Gaunt; Helen Warren; Teri-Louise Davies; Fotios Drenos; Jackie Cooper; Shah Ebrahim; Debbie A Lawlor; Philippa J Talmud; Steve E Humphries; Christine Power; Elina Hypponen; Marcus Richards; Rebecca Hardy; Diana Kuh; Nicholas Wareham; Yoav Ben-Shlomo; Ian N Day; Peter Whincup; Richard Morris; Mark W J Strachan; Jacqueline Price; Meena Kumari; Mika Kivimaki; Vincent Plagnol; John C Whittaker; George Davey Smith; Frank Dudbridge; Juan P Casas; Michael V Holmes; Aroon D Hingorani
Journal:  Lancet Diabetes Endocrinol       Date:  2016-01-16       Impact factor: 44.867
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.